혈전 제거 기기 시장 : 기술별, 유형별, 사용별, 용도별, 지역별 규모, 점유율 및 성장 분석과 산업 예측(2026-2033년)

Thrombectomy Devices Market size was valued at USD 2.01 Billion in 2024 and is poised to grow from USD 2.13 Billion in 2025 to USD 3.45 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The thrombectomy devices market is experiencing robust growth, driven by a combination of increasing cardiovascular disease prevalence, technological advancements, and an expanding aging population. Innovations in the field, such as minimally invasive devices and stent retriever technologies, have significantly enhanced patient outcomes and streamlined procedures, leading to reduced complications and faster recovery times. This surge in technology is pivotal as manufacturers prioritize research and development to create effective solutions. Additionally, the aging demographic is particularly vulnerable to cardiovascular issues and blood clots, escalating the demand for thrombectomy devices. As this population grows, the need for efficient and timely treatment solutions becomes increasingly crucial, positioning thrombectomy devices as an essential component of modern healthcare strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Thrombectomy Devices Market Segments Analysis

Global Thrombectomy Devices Market is segmented by Technology, Type, Utility, Application and region. Based on Technology, the market is segmented into Mechanical Thrombectomy, Aspiration Thrombectomy and Rheolytic Thrombectomy. Based on Type, the market is segmented into Automated Devices and Manual Devices. Based on Utility, the market is segmented into Reusable Devices and Disposable Devices. Based on Application, the market is segmented into Peripheral Diseases, Coronary Disease and Neural Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Thrombectomy Devices Market

The rising incidence of cardiovascular diseases such as strokes and heart attacks significantly propels the demand for thrombectomy devices. With an increasingly aging population and a rise in sedentary lifestyles, the prevalence of these health conditions continues to trend upward. Thrombectomy devices are essential in swiftly removing blood clots and restoring normal blood flow, which plays a crucial role in improving patient outcomes. The effectiveness of these devices in critical situations highlights their importance in medical settings, driving further interest and investment in the thrombectomy devices market as healthcare providers seek advanced solutions for managing cardiovascular emergencies.

Restraints in the Thrombectomy Devices Market

The thrombectomy devices market faces significant restraints due to the inherent risks associated with thrombectomy procedures, much like other medical interventions. Potential complications, including vessel injury, bleeding, infection, or the risk of the clot being dislodged and causing an embolism, contribute to concerns regarding safety and efficacy. These apprehensions can affect the choices made by healthcare providers and patients, ultimately influencing the acceptance and adoption of thrombectomy devices. As concerns about potential adverse outcomes persist, they may hinder the overall growth and advancement of the market, as stakeholders remain cautious in their approach to these medical devices.

Market Trends of the Thrombectomy Devices Market

The thrombectomy devices market is experiencing significant growth driven by the rising incidence of ischemic strokes, prompting a surge in demand for advanced medical interventions. Major industry players are increasingly channeling resources into research and development to innovate and enhance product offerings, particularly focusing on sophisticated technologies such as suction devices, clot retrievers, and aspiration catheters tailored for effective ischemic stroke management. These next-generation devices are engineered with enhanced tracking capabilities, streamlined clot retrieval processes, and user-friendly designs, which facilitate improved procedural efficiency for healthcare professionals. As a result, this focus on technological advancement is poised to uplift patient outcomes and reshape treatment paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thrombectomy Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Rheolytic Thrombectomy

Global Thrombectomy Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Automated Devices
• Manual Devices

Global Thrombectomy Devices Market Size by Utility & CAGR (2026-2033)

• Market Overview
• Reusable Devices
• Disposable Devices

Global Thrombectomy Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Peripheral Diseases
• Coronary Disease
• Neural Diseases

Global Thrombectomy Devices Market Size & CAGR (2026-2033)

• North America (Technology, Type, Utility, Application)
  • US
  • Canada
• Europe (Technology, Type, Utility, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Type, Utility, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Type, Utility, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Type, Utility, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerenovus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Extrusion (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations